NZ199817A - Anthelmintic composition consisting of two components - Google Patents

Anthelmintic composition consisting of two components

Info

Publication number: NZ199817A
Authority: NZ; New Zealand
Prior art keywords: benzimidazole; composition; anthelmintic; chloro; compounds
Prior art date: 1981-02-23

Application number

NZ199817A

Other languages

English (en)

Inventor

N Kitano

Original Assignee

Sankyo Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1981-02-23

Filing date

1982-02-23

Publication date

1984-12-14

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=12155318&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ199817(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1982-02-23 Application filed by Sankyo Co filed Critical Sankyo Co

1984-12-14 Publication of NZ199817A publication Critical patent/NZ199817A/en

Links

239000000203 mixture Substances 0.000 title claims description 31
230000000507 anthelmentic effect Effects 0.000 title claims description 16
150000001875 compounds Chemical class 0.000 claims description 30
HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 claims description 18
229940124339 anthelmintic agent Drugs 0.000 claims description 15
239000000921 anthelmintic agent Substances 0.000 claims description 15
239000003242 anti bacterial agent Substances 0.000 claims description 15
229940088710 antibiotic agent Drugs 0.000 claims description 15
SKZKKFZAGNVIMN-UHFFFAOYSA-N Salicilamide Chemical compound NC(=O)C1=CC=CC=C1O SKZKKFZAGNVIMN-UHFFFAOYSA-N 0.000 claims description 9
AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 claims description 9
229960000581 salicylamide Drugs 0.000 claims description 9
150000002537 isoquinolines Chemical class 0.000 claims description 6
-1 2-chloro-4-nitrophenyl Chemical group 0.000 claims description 5
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims description 4
239000003120 macrolide antibiotic agent Substances 0.000 claims description 4
WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 claims description 2
YRWLZFXJFBZBEY-UHFFFAOYSA-N N-(6-butyl-1H-benzimidazol-2-yl)carbamic acid methyl ester Chemical compound CCCCC1=CC=C2N=C(NC(=O)OC)NC2=C1 YRWLZFXJFBZBEY-UHFFFAOYSA-N 0.000 claims 1
MQXGOXSJWNZQNG-UHFFFAOYSA-N ethyl n-(6-ethoxy-1h-benzimidazol-2-yl)carbamate Chemical compound C1=C(OCC)C=C2NC(NC(=O)OCC)=NC2=C1 MQXGOXSJWNZQNG-UHFFFAOYSA-N 0.000 claims 1
ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 claims 1
230000002195 synergetic effect Effects 0.000 claims 1
244000045947 parasite Species 0.000 description 18
241001465754 Metazoa Species 0.000 description 11
241000282472 Canis lupus familiaris Species 0.000 description 9
238000000862 absorption spectrum Methods 0.000 description 9
230000000694 effects Effects 0.000 description 9
229960002669 albendazole Drugs 0.000 description 8
HXHWSAZORRCQMX-UHFFFAOYSA-N albendazole Chemical compound CCCSC1=CC=C2NC(NC(=O)OC)=NC2=C1 HXHWSAZORRCQMX-UHFFFAOYSA-N 0.000 description 8
FSVJFNAIGNNGKK-UHFFFAOYSA-N 2-[cyclohexyl(oxo)methyl]-3,6,7,11b-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4-one Chemical compound C1C(C2=CC=CC=C2CC2)N2C(=O)CN1C(=O)C1CCCCC1 FSVJFNAIGNNGKK-UHFFFAOYSA-N 0.000 description 7
229960001920 niclosamide Drugs 0.000 description 7
RJMUSRYZPJIFPJ-UHFFFAOYSA-N niclosamide Chemical compound OC1=CC=C(Cl)C=C1C(=O)NC1=CC=C([N+]([O-])=O)C=C1Cl RJMUSRYZPJIFPJ-UHFFFAOYSA-N 0.000 description 7
229960002957 praziquantel Drugs 0.000 description 7
239000004480 active ingredient Substances 0.000 description 6
241000283707 Capra Species 0.000 description 5
241000242541 Trematoda Species 0.000 description 5
238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 5
238000004809 thin layer chromatography Methods 0.000 description 5
241001489151 Trichuris Species 0.000 description 4
244000005700 microbiome Species 0.000 description 4
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
241000243974 Haemonchus contortus Species 0.000 description 3
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
241000244206 Nematoda Species 0.000 description 3
241000242678 Schistosoma Species 0.000 description 3
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
241000187747 Streptomyces Species 0.000 description 3
238000011888 autopsy Methods 0.000 description 3
210000003608 fece Anatomy 0.000 description 3
238000009472 formulation Methods 0.000 description 3
239000007903 gelatin capsule Substances 0.000 description 3
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
239000002904 solvent Substances 0.000 description 3
241001147672 Ancylostoma caninum Species 0.000 description 2
241000244160 Echinococcus Species 0.000 description 2
241000243976 Haemonchus Species 0.000 description 2
241000404582 Hymenolepis <angiosperm> Species 0.000 description 2
241001137882 Nematodirus Species 0.000 description 2
241000510960 Oesophagostomum Species 0.000 description 2
241000244031 Toxocara Species 0.000 description 2
241000244030 Toxocara canis Species 0.000 description 2
150000001556 benzimidazoles Chemical class 0.000 description 2
230000037396 body weight Effects 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
239000002552 dosage form Substances 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000003814 drug Substances 0.000 description 2
208000015181 infectious disease Diseases 0.000 description 2
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
210000004072 lung Anatomy 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
238000000034 method Methods 0.000 description 2
239000000126 substance Substances 0.000 description 2
239000000725 suspension Substances 0.000 description 2
KPZGRMZPZLOPBS-UHFFFAOYSA-N 1,3-dichloro-2,2-bis(chloromethyl)propane Chemical compound ClCC(CCl)(CCl)CCl KPZGRMZPZLOPBS-UHFFFAOYSA-N 0.000 description 1
RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
241001147657 Ancylostoma Species 0.000 description 1
241000204727 Ascaridia Species 0.000 description 1
241000244186 Ascaris Species 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
239000004215 Carbon black (E152) Substances 0.000 description 1
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
241000283086 Equidae Species 0.000 description 1
241000242711 Fasciola hepatica Species 0.000 description 1
241001263042 Fasciola sp. Species 0.000 description 1
241001126309 Fasciolopsis Species 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
241000287828 Gallus gallus Species 0.000 description 1
241000920462 Heterakis Species 0.000 description 1
241000282414 Homo sapiens Species 0.000 description 1
239000005909 Kieselgur Substances 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
241001480234 Paragonimus westermani Species 0.000 description 1
241000244187 Parascaris Species 0.000 description 1
208000030852 Parasitic disease Diseases 0.000 description 1
235000019483 Peanut oil Nutrition 0.000 description 1
241001494479 Pecora Species 0.000 description 1
241000364057 Peoria Species 0.000 description 1
241000617809 Sinum Species 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
241000282887 Suidae Species 0.000 description 1
241000244159 Taenia saginata Species 0.000 description 1
241000607216 Toxascaris Species 0.000 description 1
229920001938 Vegetable gum Polymers 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
239000000440 bentonite Substances 0.000 description 1
229910000278 bentonite Inorganic materials 0.000 description 1
SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
239000002775 capsule Substances 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
238000002512 chemotherapy Methods 0.000 description 1
235000013330 chicken meat Nutrition 0.000 description 1
238000004440 column chromatography Methods 0.000 description 1
239000000470 constituent Substances 0.000 description 1
235000012343 cottonseed oil Nutrition 0.000 description 1
239000002385 cottonseed oil Substances 0.000 description 1
125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
229960001760 dimethyl sulfoxide Drugs 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
235000013601 eggs Nutrition 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
208000006275 fascioliasis Diseases 0.000 description 1
238000000855 fermentation Methods 0.000 description 1
230000004151 fermentation Effects 0.000 description 1
239000000945 filler Substances 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
229930195733 hydrocarbon Natural products 0.000 description 1
150000002430 hydrocarbons Chemical class 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
231100000566 intoxication Toxicity 0.000 description 1
230000035987 intoxication Effects 0.000 description 1
239000008101 lactose Substances 0.000 description 1
239000007788 liquid Substances 0.000 description 1
244000144972 livestock Species 0.000 description 1
210000001365 lymphatic vessel Anatomy 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
239000000463 material Substances 0.000 description 1
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
238000002156 mixing Methods 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
231100000252 nontoxic Toxicity 0.000 description 1
230000003000 nontoxic effect Effects 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
JYWIYHUXVMAGLG-UHFFFAOYSA-N oxyclozanide Chemical compound OC1=C(Cl)C=C(Cl)C=C1NC(=O)C1=C(O)C(Cl)=CC(Cl)=C1Cl JYWIYHUXVMAGLG-UHFFFAOYSA-N 0.000 description 1
206010033675 panniculitis Diseases 0.000 description 1
230000000590 parasiticidal effect Effects 0.000 description 1
239000002297 parasiticide Substances 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
239000000312 peanut oil Substances 0.000 description 1
239000008188 pellet Substances 0.000 description 1
239000006187 pill Substances 0.000 description 1
244000144977 poultry Species 0.000 description 1
235000013594 poultry meat Nutrition 0.000 description 1
239000000843 powder Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
239000000741 silica gel Substances 0.000 description 1
229910002027 silica gel Inorganic materials 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000000243 solution Substances 0.000 description 1
241000894007 species Species 0.000 description 1
238000005507 spraying Methods 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
210000004304 subcutaneous tissue Anatomy 0.000 description 1
125000001424 substituent group Chemical group 0.000 description 1
239000003826 tablet Substances 0.000 description 1
239000000454 talc Substances 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
235000012222 talc Nutrition 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
238000011200 topical administration Methods 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NZ199817A 1981-02-23 1982-02-23 Anthelmintic composition consisting of two components NZ199817A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP56025058A JPS57139012A (en)	1981-02-23	1981-02-23	Anthelmintic composition

Publications (1)

Publication Number	Publication Date
NZ199817A true NZ199817A (en)	1984-12-14

Family

ID=12155318

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NZ199817A NZ199817A (en)	1981-02-23	1982-02-23	Anthelmintic composition consisting of two components

Country Status (10)

Country	Link
US (1)	US4468390A (2)
EP (1)	EP0059074B1 (2)
JP (1)	JPS57139012A (2)
AU (1)	AU552403B2 (2)
DE (2)	DE10299008I2 (2)
GB (1)	GB2093695B (2)
IE (1)	IE52364B1 (2)
NL (1)	NL300082I1 (2)
NZ (1)	NZ199817A (2)
ZA (1)	ZA821135B (2)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6214367B1 (en)	1996-06-05	2001-04-10	Ashmont Holdings Limited	Injectable compositions
AU2003236405B2 (en) *	1999-04-14	2007-10-25	Merial Ltd	Anthelmintic Composition
US7638545B1 (en)	1999-04-14	2009-12-29	Merial Limited	Anthelmintic composition

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2753377B1 (fr) *	1996-09-19	1999-09-24	Rhone Merieux	Nouvelle association parasiticide a base de 1-n-phenylpyra- zoles et de lactones macrocycliques endectocides
US6426333B1 (en) *	1996-09-19	2002-07-30	Merial	Spot-on formulations for combating parasites
MA19678A1 (fr) *	1982-01-13	1983-10-01	Ciba Geigy Ag	Agents anti-helmintiques.
DE3410348A1 (de) *	1984-03-21	1985-10-03	Helmut Dr. Bozen Schwienbacher	Verfahren zur bekaempfung von fischmykosen und mittel zur durchfuehrung des verfahrens
ES2054962T3 (es) *	1986-01-25	1994-08-16	Hoechst Ag	Agentes plaguicidas.
GB9024924D0 (en) *	1990-11-16	1991-01-02	Beecham Group Plc	Novel compositions
AU691990B2 (en) *	1994-11-28	1998-05-28	Virbac S.A.	Equine anthelmintic formulations
AUPM969994A0 (en)	1994-11-28	1994-12-22	Virbac S.A.	Equine anthelmintic formulations
DE19520275A1 (de) *	1995-06-02	1996-12-05	Bayer Ag	Endoparasitizide Mittel
FR2739778B1 (fr) *	1995-10-13	1997-12-12	Virbac Lab	Formulation topique destinee a traiter la maladie de la douve du foie chez l'animal
DE19654079A1 (de)	1996-12-23	1998-06-25	Bayer Ag	Endo-ekto-parasitizide Mittel
US6733767B2 (en) *	1998-03-19	2004-05-11	Merck & Co., Inc.	Liquid polymeric compositions for controlled release of bioactive substances
US6893652B2 (en)	2001-08-27	2005-05-17	Wyeth	Endoparasiticidal gel composition
US20060205681A1 (en) *	2002-06-21	2006-09-14	Maryam Moaddeb	Homogenous paste formulations
US7001889B2 (en) *	2002-06-21	2006-02-21	Merial Limited	Anthelmintic oral homogeneous veterinary pastes
US20040077703A1 (en) *	2002-10-02	2004-04-22	Soll Mark D.	Nodulisporic acid derivative spot-on formulations for combating parasites
BRPI0409185B1 (pt) *	2003-04-04	2018-05-15	Merial, Inc	Formulações veterinárias anti-helmínticas tópicas
ATE534900T1 (de) *	2003-07-09	2011-12-15	Life Technologies Corp	Verfahren zum testen einer protein-protein- wechselwirkung
US7396819B2 (en)	2003-08-08	2008-07-08	Virbac Corporation	Anthelmintic formulations
US7671034B2 (en)	2003-12-19	2010-03-02	Merial Limited	Stabilized formulation of ivermectin feed premix with an extended shelf life
WO2005094210A2 (en)	2004-03-12	2005-10-13	The Hartz Mountain Corporation	Multi-action anthelmintic formulations
US20050226908A1 (en) *	2004-04-07	2005-10-13	Akzo Nobel N.V.	Efficacious composition of a benzimidazole, an avermectin and praziquantel and related methods of use
GB0508993D0 (en) *	2005-05-03	2005-06-08	Syngenta Participations Ag	Pesticidal compositions
US8362086B2 (en)	2005-08-19	2013-01-29	Merial Limited	Long acting injectable formulations
US20080027011A1 (en) *	2005-12-20	2008-01-31	Hassan Nached	Homogeneous paste and gel formulations
CA2656617C (en)	2006-07-05	2014-10-14	Aventis Agriculture	1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof
US7919522B2 (en) *	2007-05-03	2011-04-05	Merial Limited	Compositions comprising C-13 alkoxyether macrolide compounds and phenylpyrazole compounds
ES2597083T3 (es)	2007-05-15	2017-01-13	Merial, Inc.	Compuestos de ariloazol-2-il cianoetilamino, procedimiento de fabricación y procedimiento de utilización de los mismos
CA2706448C (en)	2007-11-26	2016-08-16	Merial Limited	Solvent systems for pour-on formulations for combating parasites
WO2010042395A1 (en)	2008-10-08	2010-04-15	Wyeth Llc	Benzimidazole anthelmintic compositions
MY153715A (en)	2008-11-14	2015-03-13	Merial Ltd	Enantiomerically enriched aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
ES2781828T3 (es)	2008-11-19	2020-09-08	Boehringer Ingelheim Animal Health Usa Inc	Composiciones que comprenden un aril pirazol y/o una formamidina, procedimientos y usos de las mismas
BRPI1009199A2 (pt)	2009-03-17	2016-03-08	Concert Pharmaceuticals Inc	compostos de pirazinoisoquinolina
ES2546100T3 (es)	2009-12-04	2015-09-18	Merial, Inc.	Compuestos pesticidas bis-organosulfurados
EP3078664B1 (en)	2009-12-17	2019-02-20	Merial Inc.	Antiparasitic dihydroazole compositions
UA108641C2 (uk)	2010-04-02	2015-05-25		Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування
NZ610547A (en)	2010-11-16	2015-07-31	Merial Ltd	Novel monensin derivatives for the treatment and prevention of protozoal infections
WO2013003168A1 (en)	2011-06-27	2013-01-03	Merial Limited	Novel insect-repellent coumarin derivatives, syntheses, and methods of use
ES2618813T3 (es)	2011-06-27	2017-06-22	Merial, Inc.	Compuestos y composiciones de éter amido-piridílico y uso contra los parásitos
PL3172964T3 (pl)	2011-09-12	2021-03-08	Boehringer Ingelheim Animal Health USA Inc.	Kompozycje przeciwpasożytniczne zawierające izoksazolinową substancję czynną, sposób i ich zastosowania
US20130079394A1 (en)	2011-09-23	2013-03-28	Cnrs (Centre National Recherche Scientifique)	Indirect modeling of new repellent molecules active against insects, acarids, and other arthropods
CN104023720B (zh)	2011-11-17	2016-10-26	梅里亚有限公司	包含芳基吡唑和取代咪唑的组合物，其方法和用途
LT2811998T (lt)	2012-02-06	2019-02-25	Merial, Inc.	Paraziticidinės peroralinės veterinarinės kompozicijos, apimančios sistemiškai veikiančius aktyviuosius agentus, būdai ir jų panaudojimas
JO3626B1 (ar)	2012-02-23	2020-08-27	Merial Inc	تركيبات موضعية تحتوي على فيبرونيل و بيرميثرين و طرق استخدامها
NZ701185A (en)	2012-04-20	2015-08-28	Merial Ltd	Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof
PL2922845T3 (pl)	2012-11-20	2018-11-30	Merial, Inc.	Związki przeciwrobacze oraz ich kompozycje i sposób stosowania
SMT201800309T1 (it)	2013-01-31	2018-07-17	Merial Inc	Metodo per trattare e curare leishmaniosi utilizzando fexinidazolo
DK3063144T3 (da)	2013-11-01	2021-10-25	Boehringer Ingelheim Animal Health Usa Inc	Antiparasitære og pesticid-isoxazolinforbindelser
BR112016023898A8 (pt)	2014-04-17	2021-03-30	Basf Se	uso de compostos malononitrila para proteger animais de parasitas
CA2949511A1 (en)	2014-05-19	2015-11-26	Merial, Inc.	Anthelmintic compounds
CN106536481B (zh)	2014-06-19	2019-11-22	勃林格殷格翰动物保健美国公司	包含吲哚衍生物的杀寄生物的组合物、其用法和用途
WO2016069983A1 (en)	2014-10-31	2016-05-06	Merial, Inc.	Parasiticidal composition comprising fipronil
UY36570A (es)	2015-02-26	2016-10-31	Merial Inc	Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas
EA036272B1 (ru)	2015-04-08	2020-10-21	БЁРИНГЕР ИНГЕЛЬХАЙМ ЭНИМАЛ ХЕЛТ ЮЭсЭй ИНК.	Инъецируемые препараты замедленного высвобождения, содержащие изоксазолиновое действующее вещество, способы и применение
CN107835818B (zh)	2015-05-20	2022-04-29	勃林格殷格翰动物保健美国公司	驱虫缩酚酸肽化合物
EP3303385A2 (en)	2015-05-27	2018-04-11	Merial, Inc.	Compositions containing antimicrobial igy antibodies, for treatment and prevention of disorders and diseases caused by oral health compromising (ohc) microorganisms
UY40429A (es)	2016-02-24	2023-10-13	Boehringer Ingelheim Animal Health Usa Inc	Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
WO2018039508A1 (en)	2016-08-25	2018-03-01	Merial, Inc.	Method for reducing unwanted effects in parasiticidal treatments
AU2017344097A1 (en)	2016-10-14	2019-05-02	Boehringer Ingelheim Animal Health USA Inc.	Pesticidal and parasiticidal vinyl isoxazoline compounds
EP3541789A1 (en)	2016-11-16	2019-09-25	Boehringer Ingelheim Animal Health USA Inc.	Anthelmintic depsipeptide compounds
US11147273B2 (en)	2017-06-26	2021-10-19	Boehringer Ingelheim Animal Health USA Inc.	Dual active parasiticidal granule compositions, methods and uses thereof
MX2020001724A (es)	2017-08-14	2020-07-29	Boehringer Ingelheim Animal Health Usa Inc	Compuestos de pirazol-isoxazolina plaguicidas y parasiticidas.
US11583545B2 (en)	2018-02-08	2023-02-21	Boehringer Ingelheim Animal Health USA Inc.	Parasiticidal compositions comprising eprinomectin and praziquantel, methods and uses thereof
US12269822B2 (en)	2018-07-09	2025-04-08	Boehringer Ingelheim Animal Health USA Inc.	Anthelminthic heterocyclic compounds
WO2020112374A1 (en)	2018-11-20	2020-06-04	Boehringer Ingelheim Animal Health USA Inc.	Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof
WO2020150032A1 (en)	2019-01-16	2020-07-23	Boehringer Ingelheim Animal Health USA Inc.	Topical compositions comprising a neonicotinoid and a macrocyclic lactone, methods and uses thereof
UY38599A (es)	2019-03-01	2020-08-31	Boehringer Ingelheim Animal Health Usa Inc	Composiciones inyectables de clorsulón, sus métodos y usos
MX2021011302A (es)	2019-03-19	2022-01-19	Boehringer Ingelheim Animal Health Usa Inc	Compuestos de aza-benzotiofeno y aza-benzofurano como antihelminticos.
EP4003292A1 (en)	2019-07-22	2022-06-01	Intervet International B.V.	Soft chewable veterinary dosage form
KR20230028268A (ko)	2020-05-29	2023-02-28	뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드	구충성 헤테로시클릭 화합물
CN116897044A (zh)	2020-12-21	2023-10-17	勃林格殷格翰动物保健有限公司	包含异噁唑啉化合物的杀寄生虫环
WO2025257633A1 (en)	2024-06-12	2025-12-18	Boehringer Ingelheim Vetmedica Gmbh	Long-acting castor oil-containing injectable formulations and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS4914624A (2) *	1972-06-08	1974-02-08
PH15982A (en) *	1977-10-03	1983-05-18	Merck & Co Inc	Selective hydrogenation producta of c-076 compounds and derivatives thereof
US4144352A (en) *	1977-12-19	1979-03-13	Merck & Co., Inc.	Milbemycin compounds as anthelmintic agents
US4203976A (en) *	1978-08-02	1980-05-20	Merck & Co., Inc.	Sugar derivatives of C-076 compounds
US4289760A (en) *	1980-05-02	1981-09-15	Merck & Co., Inc.	23-Keto derivatives of C-076 compounds

1981
- 1981-02-23 JP JP56025058A patent/JPS57139012A/ja active Granted
1982
- 1982-02-18 GB GB8204765A patent/GB2093695B/en not_active Expired
- 1982-02-18 DE DE2002199008 patent/DE10299008I2/de active Active
- 1982-02-18 DE DE8282300829T patent/DE3260921D1/de not_active Expired
- 1982-02-18 EP EP82300829A patent/EP0059074B1/en not_active Expired
- 1982-02-22 ZA ZA821135A patent/ZA821135B/xx unknown
- 1982-02-22 US US06/350,641 patent/US4468390A/en not_active Expired - Lifetime
- 1982-02-22 IE IE369/82A patent/IE52364B1/en active Protection Beyond IP Right Term
- 1982-02-23 NZ NZ199817A patent/NZ199817A/en unknown
- 1982-02-23 AU AU80711/82A patent/AU552403B2/en not_active Expired
2002
- 2002-02-13 NL NL300082C patent/NL300082I1/nl unknown

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6214367B1 (en)	1996-06-05	2001-04-10	Ashmont Holdings Limited	Injectable compositions
US6663879B2 (en)	1996-06-05	2003-12-16	Ashmont Holdings Limited	Injectable compositions
AU2003236405B2 (en) *	1999-04-14	2007-10-25	Merial Ltd	Anthelmintic Composition
US7638545B1 (en)	1999-04-14	2009-12-29	Merial Limited	Anthelmintic composition

Also Published As

Publication number	Publication date
JPH0125722B2 (2)	1989-05-19
EP0059074A1 (en)	1982-09-01
IE52364B1 (en)	1987-09-30
ZA821135B (en)	1983-02-23
JPS57139012A (en)	1982-08-27
DE10299008I1 (de)	2002-07-04
NL300082I1 (nl)	2002-04-02
US4468390A (en)	1984-08-28
IE820369L (en)	1982-08-23
EP0059074B1 (en)	1984-10-10
GB2093695A (en)	1982-09-08
AU8071182A (en)	1982-09-02
DE3260921D1 (en)	1984-11-15
GB2093695B (en)	1984-03-28
AU552403B2 (en)	1986-05-29
DE10299008I2 (de)	2004-10-21

Publication	Publication Date	Title
NZ199817A (en)	1984-12-14	Anthelmintic composition consisting of two components
DE3031756C2 (2)	1989-11-23
Wolff et al.	1983	Efficacy of triclabendazole against Fasciola hepatica in sheep and goats
DE69902526T2 (de)	2003-04-03	Verbesserung der antibakteriellen wirkung von oxazolidinon durch arginin derivate
JPH0822870B2 (ja)	1996-03-06	４″−デオキシ−４″−エピ−メチルアミノアベルメクチンＢｌａ／Ｂｌｂの安定塩
JPS58167591A (ja)	1983-10-03	４”―アミノ―４”―デオキシアベルメクチン化合物及びその置換アミノ誘導体
EP3191086B1 (en)	2021-05-05	Thymol and carvacol for use in medicine
CH640237A5 (de)	1983-12-30	3-(2-(n-acetylamino)-vinylthio)-6-(hydroxyethyl)-7-oxo-1-azabicyclo-(3.2.0)hept-2-en-2-carbonsaeure und verfahren zu deren herstellung.
NZ226372A (en)	1990-04-26	Composition for preventing fescue toxicosis in animals; containing avermectin or milbemycin derivatives
JP7780094B2 (ja)	2025-12-04	非ヒト動物用抗菌剤
US10238677B2 (en)	2019-03-26	Treatment of filarial diseases
Samuelsen et al.	1997	Pharmacokinetic and efficacy studies on bath‐administering potentiated sulphonamides in Atlantic halibut, Hippoglossus hippoglossus L.
AU680290B2 (en)	1997-07-24	Antiparasitic agents
EP0125004B1 (en)	1987-04-08	Synergistic antiparasitic compositions
US4479960A (en)	1984-10-30	Anthelminthic pour-on veterinary composition
JPH0374397A (ja)	1991-03-28	アベルメクチン誘導体
RU2033150C1 (ru)	1995-04-20	Препарат для лечения и профилактики псороптоза у животных "аверсект"
NZ250465A (en)	1995-10-26	Bactericidal composition; contains macrolide antibiotic, use for treating aquatic species
DE3879792T2 (de)	1993-10-14	Gerichtete-Biosynthese eines Milbemycinanaloges.
US3993760A (en)	1976-11-23	Pyrazinoisoquinolines as anthelmintic agents
JPS63119485A (ja)	1988-05-24	Ｌｌ−ｆ２８２４９の２３−デオキシ誘導体
DE3788034T2 (de)	1994-05-26	Delta 23-Derivate von LL-F28249-Verbindungen.
US4070476A (en)	1978-01-24	Topical anthelmintic compositions and methods of use
Kabir et al.	2022	Assessment of acaricidal efficacy of ivermectin against ectoparasitic skin lesions in goats
US3993759A (en)	1976-11-23	Anthelmintic